Journal DOI 10.68956/journal.human-performance-futures

Creative Commons source reading · Return-to-sport readiness

Porcine Collagen Injection Therapy Affects Proximal Hamstring Tendinopathy in Athletes by Reducing Time to Return to Sport

Matteo Baldassarri; Sarino Ricciardello; Diego Ghinelli; Luca Perazzo; Roberto Buda

Originally published in Sports (Basel) · 2025-10-10

From the article

Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.

Abstract

Background: Proximal hamstring tendinopathy (PHT) is a challenging overuse injury, particularly in athletes, characterized by deep buttock pain localized to the ischial tuberosity and often exacerbated by sports activities. This condition can impact an athlete’s performance, limiting high-level athletic activity. Return to sport (RTS) thus becomes a medical, physical, athletic, and economic necessity. Previous research has explored several conservative and injection-based therapies, but evidence regarding the efficacy of porcine collagen injections remains limited. Therefore, this study aims to compare the results obtained from ultrasound-guided porcine collagen injections versus a structured rehabilitation program in reducing time to return to sport (RTS) and improving Victorian Institute of Sport Assessment—Hamstring (VISA-H) scores…

3.4. Return to Sport (RTS) Results

Time to return to sport (RTS) is the most important parameter from both the clinicians’ and athletes’ points of view. The RTS analyses revealed that the COL and REHAB treatments had different time intervals to RTS after treatment. The COL group had a mean time to RTS of 57 ± 5.588 days (about 8 weeks), while the REHAB group had a mean of 72.50 ± 17.51 days. The minimum and the maximum values for time to RTS were 47 and 95 days, respectively (concerning both treatments). The confidence intervals (CI; 95%) were 53.77–60.23 days for the COL treatment and 62.30–82.61 days for the REHAB treatment. These analyses revealed statistical differences between the two treatments (p = 0.0083) based on parametric and unpaired T-Tests (Figure 4). Analyses of the parametric distribution are reported in Table 2. These data suggest that the COL…

3.5. VISA-H Score Results in the COL Treatment

The VISA-H questionnaire scores were used to evaluate the clinical condition of all athletes in the COL treatment during follow-up until the time to RTS. Comparisons between the starting point (T0) and the end point (T1) were made separately in both groups of treatment (COL and REHAB). The mean scores in the COL group were 43.50 ± 4.926 and 62.00 ± 3.305 at the T0 and T1 visits, respectively. The VISA-H scores showed statistical differences through the T-Test (parametric and paired test) analyses (p = 0.0001; Figure 5). Analyses of the parametric distribution of data are reported in Table 3. These analyses suggest that the COL treatment improves the VISA-H scores at the T1 visit (Figure 5).

Editorial reading guide

  • How were injury, recovery and exposure defined and verified?
  • Which criteria support progression, and what finding should stop or change the plan?